日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Bladder Function and Safety of Vibegron in Men With Overactive Bladder Receiving Treatment for Benign Prostatic Hyperplasia: Outcomes From the Phase 3 Randomized Controlled COURAGE Trial

维贝格隆对接受良性前列腺增生治疗的膀胱过度活动症男性患者的膀胱功能和安全性：来自3期随机对照COURAGE试验的结果

期刊:Neurourology and Urodynamics
影响因子:1.9
doi:10.1002/nau.70199
Rovner, Eric S; Owens-Grillo, Janet; Thomas, Elizabeth; Herschorn, Sender; Peters, Kenneth M; Staskin, David; Mujais, Salim
前列腺增生
RAGE
免疫/内分泌
发表日期：2026
文献求助 收藏

Gene Therapy With URO-902 (pVAX/hSlo) for the Treatment of Female Patients With Overactive Bladder and Urge Urinary Incontinence: Safety and Efficacy From a Randomized Phase 2a Trial

URO-902 (pVAX/hSlo) 基因疗法治疗女性膀胱过度活动症和急迫性尿失禁：一项随机 2a 期试验的安全性和有效性

期刊:Journal of Urology
影响因子:6.8
doi:10.1097/JU.0000000000004373
Enemchukwu, Ekene A; Kalota, Susan; Robertson, Kaiser; Ge, Sijian; Lu, Jingmei; Badger, Hanh; Mujais, Salim; Peters, Kenneth M
发表日期：2025
文献求助 收藏

Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial

维贝格隆治疗接受良性前列腺增生药物治疗的男性持续性膀胱过度活动症症状的疗效和安全性：来自3期随机对照COURAGE试验的结果

期刊:Journal of Urology
影响因子:6.8
doi:10.1097/JU.0000000000003999
Staskin, David; Owens-Grillo, Janet; Thomas, Elizabeth; Rovner, Eric; Cline, Kevin; Mujais, Salim
前列腺增生
RAGE
免疫/内分泌
发表日期：2024
文献求助 收藏

QT Interval Shortening With Isavuconazole: In Vitro and In Vivo Effects on Cardiac Repolarization

伊沙康唑缩短QT间期：体外和体内对心脏复极化的影响

期刊:Clinical Pharmacology & Therapeutics
影响因子:5.5
doi:10.1002/cpt.620
Keirns, J; Desai, A; Kowalski, D; Lademacher, C; Mujais, S; Parker, B; Schneidkraut, M J; Townsend, R; Wojtkowski, T; Yamazaki, T; Yen, M; Kowey, P R
发表日期：2017
文献求助 收藏

Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi

伊沙康唑在侵袭性曲霉病和其他丝状真菌感染患者中的暴露-反应关系

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.01034-17
Desai, Amit V; Kovanda, Laura L; Hope, William W; Andes, David; Mouton, Johan W; Kowalski, Donna L; Townsend, Robert W; Mujais, Salim; Bonate, Peter L
炎症/感染
微生物学
发表日期：2017
文献求助 收藏

Phase I trial to investigate the effect of renal impairment on isavuconazole pharmacokinetics

一项研究肾功能损害对伊沙康唑药代动力学影响的I期临床试验

期刊:European Journal of Clinical Pharmacology
影响因子:2.7
doi:10.1007/s00228-017-2213-7
Townsend, Robert W; Akhtar, Shahzad; Alcorn, Harry; Berg, Jolene K; Kowalski, Donna L; Mujais, Salim; Desai, Amit V
发表日期：2017
文献求助 收藏

Population Pharmacokinetics of Isavuconazole in Subjects with Mild or Moderate Hepatic Impairment

轻度或中度肝功能损害患者伊沙康唑的群体药代动力学

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.02942-15
Desai, Amit; Schmitt-Hoffmann, Anne-Hortense; Mujais, Salim; Townsend, Robert
发表日期：2016
文献求助 收藏

The effect of mirabegron on patient-related outcomes in patients with overactive bladder: the results of post hoc correlation and responder analyses using pooled data from three randomized Phase III trials

米拉贝隆对膀胱过度活动症患者相关结局的影响：基于三项随机 III 期试验汇总数据的事后相关性和应答者分析结果

期刊:Quality of Life Research
影响因子:2.7
doi:10.1007/s11136-014-0904-4
Castro-Diaz, D; Chapple, C R; Hakimi, Z; Blauwet, M B; Delgado-Herrera, L; Lau, W; Mujais, S
发表日期：2015
文献求助 收藏

Health-related quality of life in CKD Patients: correlates and evolution over time

慢性肾脏病患者的健康相关生活质量：相关因素及随时间的变化

期刊:Clinical Journal of the American Society of Nephrology
影响因子:7.1
doi:10.2215/CJN.05541008
Mujais, Salim K; Story, Ken; Brouillette, John; Takano, Tomoko; Soroka, Steven; Franek, Catherine; Mendelssohn, David; Finkelstein, Frederic O
发表日期：2009
文献求助 收藏

Health-related quality of life and hemoglobin levels in chronic kidney disease patients

慢性肾脏病患者的健康相关生活质量和血红蛋白水平

期刊:Clinical Journal of the American Society of Nephrology
影响因子:7.1
doi:10.2215/CJN.00630208
Finkelstein, Fredric O; Story, Kenneth; Firanek, Catherine; Mendelssohn, David; Barre, Paul; Takano, Tomoko; Soroka, Steven; Mujais, Salim
发表日期：2009
文献求助 收藏